Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use during pregnancy or to ...
Jul 30, 2025
0
0
Global experts, including several from Monash University, have developed guidelines to better manage multiple sclerosis (MS) in people over 50.
Jul 30, 2025
0
1
Regular exercise provides a wide range of benefits, including weight management, improved cardiovascular health and sleep quality. But for many people, common forms of exercise, such as walking, running and weight training, ...
Jul 29, 2025
0
1
The laminin-411 protein is vital for the formation of the myelin membrane by oligodendrocytes, report researchers from Japan. Furthermore, the A4G47 peptide from the E8 region of laminin-411 was found to be the main active ...
Jul 25, 2025
0
0
Researchers at Oregon Health & Science University have identified a gene that plays a crucial role in the brain's ability to form the protective layer around nerves known as myelin, potentially opening new doors to treatments ...
Jul 22, 2025
0
14
Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on artificial intelligence that may help people with multiple sclerosis track their symptoms—and even ...
Jul 21, 2025
0
0
A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of certainty years before the ...
Jul 14, 2025
0
14
Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also clearly related to cognition ...
Jul 8, 2025
0
0
While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better understanding of how MS happens and how best to treat it.
Jul 3, 2025
0
2
When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that depletes B cells—the immune ...
Jul 2, 2025
0
2
